Private Capital Management (Minnesota)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Private Capital Management (Minnesota)'s BMY Position: Q3 2017 in Review
Private Capital Management (Minnesota) reduced its Bristol-Myers Squibb (BMY) stake by 56% in Q3 2017, selling an estimated $301K and leaving 4,000 shares worth $255K. The position accounts for 0.29% of the portfolio, ranked #139.
Private Capital Management (Minnesota) first reported a position in BMY in Q3 2016 and has held it in 5 quarters since. The position peaked at $629K in Q3 2016. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Private Capital Management (Minnesota) held 4,000 shares of Bristol-Myers Squibb worth $255K as of Q3 2017.
- Private Capital Management (Minnesota) sold 5,150 Bristol-Myers Squibb shares in Q3 2017, an estimated $301K.
- Bristol-Myers Squibb made up 0.29% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #139 holding.
- Private Capital Management (Minnesota) first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 5 quarters since.
- Private Capital Management (Minnesota)'s Bristol-Myers Squibb position peaked at $629K in Q3 2016.
- 1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.